Open Official source
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
National Institutes of Health
- Deadline
- 2 Nov 2026Closes in 4 days
- Funding type
- Grant
- Location
- United States
Overview
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review].
The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Eligibility
Businesses are listed among eligible applicants.
Eligible applicants
- City or township governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- State governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- Small businesses
- County governments
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Special district governments
Important dates
- Published
- 9 Dec 2024
- Deadline
- 2 Nov 2026